{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:05:01Z","timestamp":1784797501841,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer and peritoneal dissemination is one major cause for this poor prognosis. Exosomes have emerged as promising biomarkers for gastrointestinal cancers and can be found in all kinds of bodily fluids, also in peritoneal fluid (PF). This is a unique sample due to its closeness to gastrointestinal malignancies. The receptor tyrosine kinase-like orphan receptor 1 (ROR1) has been identified as a potential biomarker in human cancers and represents a promising target for an immunotherapy approach, which could be considered for future treatment strategies. Here we prospectively analyzed the exosomal surface protein ROR1 (exo-ROR1) in PF in localized PDAC patients (PER-) on the one hand and peritoneal disseminated tumor stages (PER+) on the other hand followed by the correlation of exo-ROR1 with clinical-pathological parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Exosomes were isolated from PF and plasma samples of non-cancerous (NC) (n = 15), chronic pancreatitis (CP) (n = 4), localized PDAC (PER-) (n = 18) and peritoneal disseminated PDAC (PER+) (n = 9) patients and the surface protein ROR1 was detected via FACS analysis. Additionally, soluble ROR1 in PF was analyzed. ROR1 expression in tissue was investigated using western blots (WB), qPCR, and immunohistochemistry (IHC). Exosome isolation was proven by Nano Tracking Analysis (NTA), WB, Transmission electron microscopy (TEM), and BCA protein assay. The results were correlated with clinical data and survival analysis was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PDAC (PER+) patients have the highest exo-ROR1 values in PF and can be discriminated from NC (p &amp;lt;0.0001), PDAC (PER-) (p &amp;lt;0.0001), and CP (p = 0.0112). PDAC (PER-) can be discriminated from NC (p = 0.0003). In plasma, exo-ROR1 is not able to distinguish between the groups. While there is no expression of ROR1 in the exocrine pancreatic tissue, PDAC and peritoneal metastasis show expression of ROR1. High exo-ROR1 expression in PF is associated with lower overall survival (p = 0.0482).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>With exo-ROR1 in PF we found a promising diagnostic and prognostic biomarker possibly discriminating between NC, PDAC (PER-) and PDAC (PER+) and might shed light on future diagnostic and therapeutic concepts in PDAC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1253072","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:27:09Z","timestamp":1716438429000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival"],"prefix":"10.3389","volume":"15","author":[{"given":"Anke","family":"Mittelst\u00e4dt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Anthuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Podolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Krautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Denz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Hackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Buniatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Ro\u00dfdeutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Kl\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Swierzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deike","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurdag\u00fcl","family":"Zopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Ole","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Van Deun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Immanuel Geppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gie\u00dfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lettmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Semrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Kouhestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg F.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.5081","article-title":"Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: A propensity score matched analysis","volume":"35","author":"Mokdad","year":"2017","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"key":"B4","article-title":"Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasion","volume":"61","author":"Suenaga","year":"2014","journal-title":"Hepatogastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.3337","article-title":"Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: A secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial","volume":"154","author":"Jones","year":"2019","journal-title":"JAMA Surgery"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5757-3","article-title":"Percutaneous peritoneal lavage for the rapid staging of gastric and pancreatic cancer","volume":"24","author":"Pak","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2083","article-title":"Analysis of ROR1 protein expression in human cancer and normal tissues","volume":"23","author":"Balakrishnan","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.680834","article-title":"Tyrosine kinase ROR1 as a target for anti-cancer therapies","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/srep05811","article-title":"ROR1 expression correlated with poor clinical outcome in human ovarian cancer","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"36447","DOI":"10.1038\/srep36447","article-title":"ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1186\/s12885-021-08952-9","article-title":"ROR1 and ROR2 expression in pancreatic cancer","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9500","article-title":"ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer","volume":"18","author":"Xu","year":"2018","journal-title":"Mol Med Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112614","article-title":"YAP\/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer","author":"Yamazaki","year":"2023","journal-title":"EMBO J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1326437","article-title":"An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors","volume":"6","author":"Gohil","year":"2017","journal-title":"Oncoimmunol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/978-1-4613-9235-4_2","article-title":"Peritoneal fluid","volume-title":"The Peritoneum","author":"diZerega","year":"1992"},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1742271X16680653","article-title":"Ascites matters","volume":"25","author":"Rudralingam","year":"2017","journal-title":"Ultrasound"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3.22","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"3","author":"Th\u00e9ry","year":"2006","journal-title":"Curr Protoc Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00282","article-title":"Melanoma affects the composition of blood cell-derived extracellular vesicles","volume":"7","author":"Koliha","year":"2016","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29975","DOI":"10.3402\/jev.v5.29975","article-title":"A novel multiplex bead-based platform highlights the diversity of extracellular vesicles","volume":"5","author":"Koliha","year":"2016","journal-title":"J Extracell Vesicles"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9307","article-title":"Value of peritoneal cytology in potentially resectable pancreatic cancer","volume":"100","author":"Yamada","year":"2013","journal-title":"Br J Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08990-w","article-title":"Peritoneal lavage tumor DNA as a novel biomarker for predicting peritoneal recurrence in pancreatic ductal adenocarcinoma","volume":"28","author":"Suenaga","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s13238-014-0059-7","article-title":"ROR1, an embryonic protein with an emerging role in cancer biology","volume":"5","author":"Borcherding","year":"2014","journal-title":"Protein Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199007000-00019","article-title":"A prospective, randomized comparison between open and closed peritoneal lavage techniques","volume":"30","author":"Cu\u00e9","year":"1990","journal-title":"J Trauma"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199805000-00023","article-title":"Percutaneous diagnostic peritoneal lavage using a Veress needle versus an open technique: a prospective randomized trial","volume":"44","author":"Saunders","year":"1998","journal-title":"J Trauma"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001541","article-title":"Adding examples to the ASA-physical status classification improves correct assignment to patients","volume":"126","author":"Hurwitz","year":"2017","journal-title":"Anesthesiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1253072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:27:13Z","timestamp":1716438433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1253072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2024.1253072"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1253072","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"article-number":"1253072"}}